Navigation Links
BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update
Date:2/4/2010

R&D expenses decreased to $72.3 million for 2009 from $73.3 million for the prior year due to reductions in clinical development and manufacturing costs related to the forodesine program, lower costs related to toxicology studies and pre-clinical compounds, as well as a decrease in general operating and personnel related costs.  These decreases were offset by higher clinical development costs associated with peramivir and BCX4208, as well as an increase in manufacturing and consulting fees for the peramivir program.    

G&A expenses increased to $11.5 million for 2009 from $10.4 million for 2008.  This increase was primarily due to higher legal and consulting fees.

Interest income for 2009 was $0.3 million as compared to $2.4 million for the prior year, due to a lower average cash and securities balance as well as significantly lower yield earned on interest-bearing assets.

The net loss for the year ended December 31, 2009 was $13.5 million, or $0.35 per share, compared to a net loss of $24.7 million, or $0.65 per share for the year ended December 31, 2008.

For 2010, BioCryst expects cash use to be between $25 and $30 million.  Cash use will vary depending on clinical outcomes.  

Recent Program Highlights

Peramivir Program

  • On January 27, BioCryst's partner Shionogi announced the commercial launch of RAPIACTA (i.v. peramivir) to treat patients with influenza in '/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
2. BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
3. BioCryst Announces Pricing of Public Offering of Common Stock
4. BioCryst to Present at Oppenheimer Healthcare Conference
5. Emergency Use Authorization Granted For BioCrysts Peramivir
6. BioCryst to Present at JMP Securities Healthcare Conference
7. BioCryst Clarifies Government Declaration Regarding Peramivir
8. BioCryst Provides Update Regarding Peramivir for Influenza
9. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
10. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
11. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ANI Pharmaceuticals, Inc. ... has received approval from the U.S. Food and Drug ... for Oxycodone Hydrochloride Oral Solution 5mg/5mL. Trailing twelve-month sales ... with three current competitors. ANI expects to begin shipping ... Przybyl , President and CEO of ANI Pharmaceuticals, stated, ...
(Date:6/2/2015)... 2015 San MediTech, the industry leader in ... (CGM) for diabetics, announced its plan to attend the ... Boston on June 5 th ... Glucose Monitoring System (DGMS). The company plans to show ... innovative technologies and advancements made by Chinese medical device ...
(Date:6/2/2015)... -- Integrated Service Solutions, Inc. ("the Company") announced today they are expanding their reach nationally by providing customers with on-site 17025 accredited ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4
(Date:6/2/2015)... The Non-GMO Project offers North America’s ... to rigorous best practices for GMO (genetically modified ... with the Non-GMO Project Standard - that means ... inspections and an annual audit to ensure the ... Systems is and has always been wholeheartedly committed ...
(Date:6/2/2015)... a popular online store selling celebrity inspired fashion products, ... dresses. The company carries more than 1000 styles of ... a wide variety of summer events like wedding and ... quality trendy special occasion dresses and accessories. ... and cotton. Their products feature a wide range of ...
(Date:6/2/2015)... 2015 TranSlice: Reveal from Pixel Film Studios ... Reveal allows Final Cut Pro X users to transition from ... their next screen. , TranSlice Reveal brings back the split ... Pro X users can now transition from one screen ... every panel orientation and direction covered, no transition will look ...
(Date:6/2/2015)... June 02, 2015 The Radiosurgery ... study from the RSSearch® Patient Registry evaluating the ... radiotherapy (SBRT) for the treatment of centrally located ... metastases. , The study, published in the ... ), included 111 patients with 114 centrally located ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Amercanex, ... tapped Jim Miller to become Amercanex’s new Chief ... cannabis marketplace in which cultivators, wholesale distributors and ... inventories in a fully transparent intra-state market. , ... in the financial technology space, helping innovative technology ...
Breaking Medicine News(10 mins):Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Amercanex Names Jim Miller to CTO Position 2
... and other factors influence the way// individuals perceive loudness ... report. ,Tinnitus, a ringing, buzzing or whistling sound ... can be acute or chronic, constant or intermittent. Tinnitus ... unknown origin. According to background information in the article, ...
... treatment for new born babies who develop jaundice soon ... researchers say that this increases the likelihood of moles ... life. Such moles are termed melanocytic naevi in medical ... ,like melanoma ,are linked to naevi, the researchers warn ...
... Paris: To ascertain the exact reason that led to the ... France//, officials are conducting detailed tests, though preliminary investigations have ... by the ministry, the death of the birds was sudden, ... keeping healthy. The owner of the farm is pretty ...
... Gov. Ed Rendell will announce a health care reform plan ... to millions of Pennsylvanians who lack coverage. Governor added that ... ,The plan, which was under development for months, ... supported by Mr. Rendell. ,Moreover, Mr. Rendell ...
... surgical procedures may be more likely to develop pneumonia ... those without HIV, according to a report in the ... JAMA/Archives journals. In addition, HIV patients with a preoperative ... the blood) greater than 30,000 per milliliter appear to ...
... states of India migrate to the industrialized regions in India's ... AIDS.// Bihari migrants are estimated to range from two million ... security guards or domestic servants in India's big cities. ... doing," Srivastava, a Bihari aged 48, told Reporters in Patna, ...
Cached Medicine News:Health News:Clinical Factors of Tinnitus Influence Perceived Loudness and Annoyance 2Health News:HIV Patients Have Increased Risk of Pneumonia, Death Following Surgery 2Health News:Poverty Fuels HIV In Poor Indian States 2
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Made exclusively from LactoSorb® Resorbable Copolymer....
... of 25% Hydroxy-Apatite (HA) and 75% Poly-L ... the fixation strength of a titanium interference ... bone. Our wedge design makes it ideal ... increases the healing characteristic of the bone ...
Medicine Products: